{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:09:15Z","timestamp":1785546555813,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100010875","name":"Amgen Canada","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100010875","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00198-020-05554-2","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T15:03:26Z","timestamp":1595689406000},"page":"123-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A scorecard for osteoporosis in Canada and seven Canadian provinces"],"prefix":"10.1007","volume":"32","author":[{"given":"D.L.","family":"Kendler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Juby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Duperrouzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K.","family":"McTavish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Slatkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"key":"5554_CR1","unstructured":"International Osteoporosis Foundation (2013) Bone care for the postmenopausal woman. https:\/\/www.iofbonehealth.org\/reports. Accessed 18 October 2019"},{"key":"5554_CR2","unstructured":"Public Health Agency of Canada (2009) Fast facts from the 2009 Canadian Community Health Survey\u2014osteoporosis rapid response. https:\/\/www.canada.ca\/en\/public-health\/services\/chronic-diseases\/osteoporosis\/what-impact-osteoporosis-what-canadians-doing-maintain-healthy-bones.html. Accessed 28 January 2019"},{"issue":"9","key":"5554_CR3","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/jbmr.95","volume":"25","author":"C Berger","year":"2010","unstructured":"Berger C, Goltzman D, Langsetmo L, Joseph L, Jackson S, Kreiger N, Tenenhouse A, Davison KS, Josse RG, Prior JC, Hanley DA, CaMos Research Group (2010) Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 25(9):1948\u20131957","journal-title":"J Bone Miner Res"},{"key":"5554_CR4","unstructured":"Statistics Canada (2011) Canada Year Book 2012: Seniors. https:\/\/www150.statcan.gc.ca\/n1\/en\/catalogue\/11-402-X. Accessed 18 October 2019"},{"issue":"10","key":"5554_CR5","first-page":"1357","volume":"157","author":"EA Papadimitropoulos","year":"1997","unstructured":"Papadimitropoulos EA, Coyte PC, Josse RG, Greenwood CE (1997) Current and projected rates of hip fracture in Canada. CMAJ 157(10):1357\u20131363","journal-title":"CMAJ"},{"issue":"2","key":"5554_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00198-012-2034-6","volume":"24","author":"M Nikitovic","year":"2013","unstructured":"Nikitovic M, Wodchis WP, Krahn MD, Cadarette SM (2013) Direct health-care costs attributed to hip fractures among seniors: a matched cohort study. Osteoporos Int 24(2):659\u2013669","journal-title":"Osteoporos Int"},{"issue":"20","key":"5554_CR7","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1001\/jama.2017.17606","volume":"318","author":"D Pincus","year":"2017","unstructured":"Pincus D, Ravi B, Wasserstein D, Huang A, Paterson JM, Nathens AB, Kreder HJ, Jenkinson RJ, Wodchis WP (2017) Association between wait time and 30-day mortality in adults undergoing hip fracture surgery. JAMA 318(20):1994\u20132003","journal-title":"JAMA"},{"issue":"9","key":"5554_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1359\/jbmr.090319","volume":"24","author":"L Langsetmo","year":"2009","unstructured":"Langsetmo L, Goltzman D, Kovacs CS, Adachi JD, Hanley DA, Kreiger N, Josse R, Papaioannou A, Olszynski WP, Jamal SA (2009) Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res 24(9):1515\u20131522","journal-title":"J Bone Miner Res"},{"issue":"11","key":"5554_CR9","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00198-012-1931-z","volume":"23","author":"JE Tarride","year":"2012","unstructured":"Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, Papaioannou A, Bessette L, Brown JP, Goeree R (2012) The burden of illness of osteoporosis in Canada. Osteoporos Int 23(11):2591\u20132600","journal-title":"Osteoporos Int"},{"key":"5554_CR10","doi-asserted-by":"crossref","unstructured":"Hopkins RB, Burke N, Von Keyserlingk C, Leslie WD, Morin SN, Adachi JD, Papaioannou A, Bessette L, Brown JP, Pericleous L, Tarride J (2016) The current economic burden of illness of osteoporosis in Canada. Osteoporos Int 27(10):3023\u20133032","DOI":"10.1007\/s00198-016-3631-6"},{"key":"5554_CR11","unstructured":"Osteoporosis Canada (2011) Towards a Fracture-Free Future. http:\/\/fls.osteoporosis.ca\/wp-content\/uploads\/white-paper-march-2011.pdf. Accessed 28 January 2019"},{"key":"5554_CR12","unstructured":"Osteoporosis Canada (2008) Breaking barriers, Not bones: 2008 National Report Card on Osteoporosis Care. https:\/\/osteoporosis.ca\/."},{"issue":"1\u20132","key":"5554_CR13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11657-013-0144-1","volume":"8","author":"JA Kanis","year":"2013","unstructured":"Kanis JA, Borgstr\u00f6m F, Compston J, Dreinh\u00f6fer K, Nolte E, Jonsson L, Lems WF, McCloskey EV, Rizzoli R, Stenmark J (2013) SCOPE: a scorecard for osteoporosis in Europe. Arch Osteoporos 8(1\u20132):144","journal-title":"Arch Osteoporos"},{"issue":"1","key":"5554_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11657-019-0622-1","volume":"14","author":"R Aziziyeh","year":"2019","unstructured":"Aziziyeh R, Amin M, Habib M, Perlaza JG, McTavish RK, L\u00fcdke A, Fernandes S, Sripada K, Cameron C (2019) A scorecard for osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina. Arch Osteoporos 14(1):69","journal-title":"Arch Osteoporos"},{"key":"5554_CR15","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"5554_CR16","unstructured":"Canadian Agency for Drugs and Technologies in Health (2015) Grey matters: a practical tool for searching health-related grey literature. https:\/\/www.cadth.ca\/resources\/finding-evidence\/grey-matters."},{"key":"5554_CR17","unstructured":"Kaltenthaler E, Tappende P, Paisley S, Squires H (2011) NICE DSU technical support document 13: identifying and reviewing evidence to inform the conceptualisation and population of cost-effectiveness models. http:\/\/nicedsu.org.uk\/wp-content\/uploads\/2016\/03\/TSD-13-model-parameters.pdf."},{"issue":"8","key":"5554_CR18","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00198-009-1080-1","volume":"21","author":"WD Leslie","year":"2010","unstructured":"Leslie WD, O'Donnell S, Lagace C, Walsh P, Bancej C, Jean S, Siminoski K, Kaiser S, Kendler DL, Jaglal S (2010) Population-based Canadian hip fracture rates with international comparisons. Osteoporos Int 21(8):1317\u20131322","journal-title":"Osteoporos Int"},{"issue":"3","key":"5554_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00198-010-1464-2","volume":"22","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA (2011) Construction of a FRAX model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int 22(3):817\u2013827","journal-title":"Osteoporos Int"},{"key":"5554_CR20","doi-asserted-by":"crossref","unstructured":"Kanis JA, Od\u00e9n A, McCloskey EV, Johansson H, Wahl DA, Cooper C, on behalf of the IOF Working Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23 (9):2239\u20132256","DOI":"10.1007\/s00198-012-1964-3"},{"key":"5554_CR21","unstructured":"Osteoporosis Canada (2013) Make the FIRST break the LAST with Fracture Liaison Services Appendix B: fracture incidence and costs by province. http:\/\/www.osteoporosis.ca\/wp-content\/uploads\/FLS-TOOLKIT.pdf."},{"key":"5554_CR22","unstructured":"Statistics Canada (2019) Table 17-10-0005-01 Population estimates on July 1st, by age and sex. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501. Accessed 17 June 2019"},{"issue":"3","key":"5554_CR23","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00198-011-1652-8","volume":"23","author":"RB Hopkins","year":"2012","unstructured":"Hopkins RB, Pullenayegum E, Goeree R, Adachi JD, Papaioannou A, Leslie WD, Tarride JE, Thabane L (2012) Estimation of the lifetime risk of hip fracture for women and men in Canada. Osteoporos Int 23(3):921\u2013927","journal-title":"Osteoporos Int"},{"key":"5554_CR24","unstructured":"Statistics Canada (2019) Table 17-10-0057-01 Projected population, by projection scenario, age and sex, as of July 1 (x 1,000). https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710005701 Accessed 17 June 2019"},{"key":"5554_CR25","unstructured":"Royal College of Physicians and Surgeons of Canada (2019) Royal College of Physicians and Surgeons of Canada. http:\/\/www.royalcollege.ca\/rcsite\/home-e."},{"key":"5554_CR26","unstructured":"International Osteoporosis Foundation (2017) National Societies. https:\/\/www.iofbonehealth.org\/societies-country-index-view\/all. Accessed 6 December 2019"},{"key":"5554_CR27","doi-asserted-by":"crossref","unstructured":"Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD, Scientific Advisory Council of Osteoporosis Canada (2010) 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182 (17):1864\u20131873","DOI":"10.1503\/cmaj.100771"},{"issue":"3","key":"5554_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00198-004-1811-2","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johnell O (2005) Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int 16(3):229\u2013238","journal-title":"Osteoporos Int"},{"key":"5554_CR29","unstructured":"Centre for Metabolic Bone Diseases University of Sheffield (2018) FRAX: Fracture Risk Assessment Tool. https:\/\/www.sheffield.ac.uk\/FRAX\/."},{"key":"5554_CR30","unstructured":"The AGREE Next Steps Consortium (2009) Appraisal of Guidelines for REsearch & Evaluation II. https:\/\/www.agreetrust.org\/wp-content\/uploads\/2013\/10\/AGREE-II-Users-Manual-and-23-item-Instrument_2009_UPDATE_2013.pdf"},{"key":"5554_CR31","unstructured":"Osteoporosis Canada (2019) Canadian FLS Registry. https:\/\/fls.osteoporosis.ca\/canadian-fls-registry\/. Accessed 9 October 2019"},{"key":"5554_CR32","unstructured":"Canadian Institute for Health Information (2018) Quick Stats\u2014CMDB hospital beds staffed and in operation, 2017\u20132018. https:\/\/www.cihi.ca\/en\/quick-stats. Accessed 30 July 2019"},{"key":"5554_CR33","unstructured":"Index Sant\u00e9 - Le r\u00e9pertoire sant\u00e9 du Qu\u00e9bec (2019) R\u00e9pertoire des h\u00f4pitaux au Qu\u00e9bec. https:\/\/www.indexsante.ca\/."},{"key":"5554_CR34","unstructured":"Osteoporosis Canada (2018) Report from Osteoporosis Canada\u2019s first national FLS audit: leading FLS improvement in Canada. http:\/\/fls.osteoporosis.ca\/wp-content\/uploads\/Report-from-Osteoporosis-Canadas-first-national-FLS-audit.pdf."},{"key":"5554_CR35","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s11657-013-0166-8","volume":"9","author":"JA Kanis","year":"2014","unstructured":"Kanis JA, Johansson H, Oden A, Cooper C, McCloskey EV (2014) Worldwide uptake of FRAX. Arch Osteoporos 9:166","journal-title":"Arch Osteoporos"},{"key":"5554_CR36","unstructured":"Canadian Institute for Health Information (2017) Patients receiving treatment within the benchmark for hip fracture repair. http:\/\/waittimes.cihi.ca\/procedure\/fracture#year. Accessed 28 January 2019"},{"issue":"9","key":"5554_CR37","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s00198-016-3613-8","volume":"27","author":"WD Leslie","year":"2016","unstructured":"Leslie WD, Majumdar SR, Lix LM, Josse RG, Johansson H, Oden A, McCloskey EV, Kanis JA (2016) Direct comparison of FRAX(R) and a simplified fracture risk assessment tool in routine clinical practice: a registry-based cohort study. Osteoporos Int 27(9):2689\u20132695","journal-title":"Osteoporos Int"},{"issue":"3","key":"5554_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10067-014-2642-y","volume":"34","author":"R Ferrari","year":"2015","unstructured":"Ferrari R (2015) Prevalence of osteoporosis in men aged 65-75 in a primary care setting. A practice audit after application of the Canadian 2010 guidelines for osteoporosis screening. Clin Rheumatol 34(3):523\u2013527","journal-title":"Clin Rheumatol"},{"key":"5554_CR39","unstructured":"Canadian Institute for Health Information (2019) Discharge Abstract Database metadata (DAD). https:\/\/www.cihi.ca\/en\/discharge-abstract-database-metadata."},{"key":"5554_CR40","unstructured":"Ministry of Health and Long-Term Care, Osteoporosis Canada, Ontario College of Family Physicians, McMaster University, Women's College Hospital, GERAS Centre for Aging Research, St. Michael's Hospital (2019) Ontario Osteoporosis Strategy. https:\/\/www.osteostrategy.on.ca\/."},{"issue":"s1","key":"5554_CR41","first-page":"s10","volume":"55","author":"TA Proverbs-Singh","year":"2007","unstructured":"Proverbs-Singh TA, Studenski S, Cauley J, Perera S, Faulkner K, Hillier T (2007) AGS 2007 Annual Scientific Meeting Abstract P28. Which is more fatal, hip fracture or breast cancer? Survival after hip fracture and breast cancer: a comparison using the SOF database. J Am Geriatr Soc 55(s1):s10\u2013s11","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"5554_CR42","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5554_CR43","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1007\/s11999-010-1535-x","volume":"468","author":"JD Isaacs","year":"2010","unstructured":"Isaacs JD, Shidiak L, Harris IA, Szomor ZL (2010) Femoral insufficiency fractures associated with prolonged bisphosphonate therapy. Clin Orthop Relat Res 468(12):3384\u20133392","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"5554_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1759720X11416270","volume":"3","author":"CM Girgis","year":"2011","unstructured":"Girgis CM, Seibel MJ (2011) Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis 3(6):301\u2013314","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"5554_CR45","first-page":"324","volume":"60","author":"JP Brown","year":"2014","unstructured":"Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J (2014) Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician 60(4):324\u2013333","journal-title":"Can Fam Physician"},{"issue":"3","key":"5554_CR46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65(3):415\u2013423","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"5554_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68(2):243\u2013253","journal-title":"J Oral Maxillofac Surg"},{"key":"5554_CR48","unstructured":"Royal College of Physicians (2019) The National Hip Fracture Database. https:\/\/www.nhfd.co.uk\/. Accessed 25 October 2019"},{"key":"5554_CR49","unstructured":"Osteoporosis Canada (2018) Impact report 2017\u20132018. https:\/\/osteoporosis.ca\/wp-content\/uploads\/EN-Osteo-Impact-Report-F2017-2018.pdf."},{"issue":"3","key":"5554_CR50","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22(3):465\u2013475","journal-title":"J Bone Miner Res"},{"key":"5554_CR51","unstructured":"Government of Alberta (2010) Alberta population projections by Census Division, 2010\u20132050. https:\/\/open.alberta.ca\/publications\/5336155. Accessed 6 December 2019"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05554-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05554-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T23:13:01Z","timestamp":1627168381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05554-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,25]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5554"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05554-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,25]]},"assertion":[{"value":"4 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"DLK received research grants, consulting honoraria, and\/or speaking honoraria from Amgen, Pfizer, Radius, and Eli Lily. JPB received grants\/research support from Amgen, Mereo Biopharma, Radius Health, and Servier; consultant for Amgen; and speakers\u2019 bureau for Amgen, Janssen, and Orimed. JDA is a consultant, speaker, and clinical trialist for Amgen. AGJ and CSK received consulting fees from Amgen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}